Trazodone improves sleep parameters in Alzheimer disease patients: A randomized, double-blind, and placebo-controlled study

American Journal of Geriatric Psychiatry

Volumn 22, Issue 12, 2014, Pages 1565-1574

  Camargos, Einstein F ^a,b   Louzada, Luciana L ^a,b   Quintas, Juliana L ^a   Naves, Janeth O S ^a   Louzada, Fernando M ^c   Nóbrega, Otávio T ^a,b  

^a HOSPITAL UNIVERSITÁRIO DE BRASÍLIA   (Brazil)

^b UNIVERSITY OF BRASILIA   (Brazil)

^c FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Alzheimer disease; insomnia; intervention; Sleep disorders; trazodone; treatment

Indexed keywords

ALCOHOL; CAFFEINE; PLACEBO; TRAZODONE; SEROTONIN UPTAKE INHIBITOR;

ACTIMETRY; AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; COMMON COLD; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DAYTIME SOMNOLENCE; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; EMOTIONAL STRESS; EVENING DOSAGE; FEMALE; FUNCTIONAL DISEASE; HUMAN; IRRITABILITY; LEG EDEMA; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIRED ASSOCIATE LEARNING; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SLEEP DISORDER; SLEEP PARAMETERS; SLEEP PATTERN; SLEEP QUALITY; SLEEP TIME; SLEEP WAKING CYCLE; VERY ELDERLY; WECHSLER MEMORY SCALE; COGNITION DISORDERS; COMORBIDITY; SLEEP DISORDERS; TREATMENT OUTCOME;

ACTIGRAPHY; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITION DISORDERS; COMORBIDITY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; SEROTONIN UPTAKE INHIBITORS; SLEEP DISORDERS; TRAZODONE; TREATMENT OUTCOME;

EID: 84928205385     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1016/j.jagp.2013.12.174     Document Type: Article

References (32)

1. Vitiello MV, Borson S: Sleep disturbances in patients with Alzheimer's disease: epidemiology, pathophysiology and treatment. CNS Drugs 2001; 15:777-796
2. Hope T, Keene J, Gedling K, et al: Predictors of institutionalization for people with dementia living at home with a carer. Int J Geriatr Psychiatry 1998; 13:682-690
3. Ancoli-Israel S, Klauber MR, Gillin JC, et al: Sleep in noninstitutionalized Alzheimer's disease patients. Aging (Milano) 1994; 6:451-458
4. McCurry SM, Pike KC, Vitiello MV, et al: Increasing walking and bright light exposure to improve sleep in community-dwelling persons with Alzheimer's disease: results of a randomized, controlled trial. J Am Geriatr Soc 2011; 59:1393-1402
5. McCurry SM, Gibbons LE, Logsdon RG, et al: Nighttime insomnia treatment and education for Alzheimer's disease: a randomized, controlled trial. J Am Geriatr Soc 2005; 53:793-802
6. Camargos EF, Louzada FM, Nóbrega OT: Wrist actigraphy for measuring sleep in intervention studies with Alzheimer's disease patients: application, usefulness, and challenges. Sleep Med Rev 2013; 18:475-488
7. Glass J, Lanctot KL, Herrmann N, et al: Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 2005; 331:1169
8. Camargos EF, Oliveira LF, Boaventura TD, et al: Mianserin for the treatment of sleep disorders in patients with dementia: a retrospective open-label study. J Clin Psychopharmacol 2012; 32: 576-578
9. Camargos EF, Pandolfi MB, Freitas MP, et al: Trazodone for the treatment of sleep disorders in dementia: an open-label, observational and review study. Arq Neuropsiquiatr 2011; 69:44-49
10. National Institutes of Health State of the Science: Conference statement on manifestations and management of chronic insomnia in adults, June 13-15, 2005. Sleep 2005; 28:1049-1057
11. Bossini L, Casolaro I, Koukouna D, et al: Off-label uses of trazodone: a review. Expert Opin Pharmacother 2012; 13:1707-1717
12. James SP, Mendelson WB: The use of trazodone as a hypnotic: a critical review. J Clin Psychiatry 2004; 65:752-755
13. Ancoli-Israel S, Clopton P, Klauber MR, et al: Use of wrist activity for monitoring sleep/wake in demented nursing-home patients. Sleep 1997; 20:24-27
14. Morgenthaler T, Alessi C, Friedman L, et al: Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. Sleep 2007; 30:519-529
15. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944
16. Folstein MF, Folstein SE, McHugh PR: "Miniemental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
17. Rosen WG, Terry RD, Fuld PA, et al: Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980; 7:486-488
18. Cummings JL, Mega M, Gray K, et al: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44:2308-2314
19. Yesavage JA, Friedman L, Ancoli-Israel S, et al: Development of diagnostic criteria for defining sleep disturbance in Alzheimer's disease. J Geriatr Psychiatry Neurol 2003; 16:131-139
20. Katz S: Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living. J Am Geriatr Soc 1983; 31:721-727
21. Wechsler D: WMS-III Wechsler Memory Scale. San Antonio, TX, Psychological Corporation, 1997
22. Wechsler D: WAIS-III Wechsler Adult Intelligence Scale. San Antonio, TX, Psychological Corporation, 1997
23. Alexopoulos GS, Abrams RC, Young RC, et al: Cornell Scale for Depression in Dementia. Biol Psychiatry 1988; 23:271-284
24. Hughes CP, Berg L, Danziger WL, et al: A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140:566-572
25. Stahl SM: Mechanism of action of trazodone: a multifunctional drug. CNS Spectr 2009; 14:536-546
26. Singer C, Tractenberg RE, Kaye J, et al: A multicenter, placebocontrolled trial of melatonin for sleep disturbance in Alzheimer's disease. Sleep 2003; 26:893-901
27. McCarten JR, Kovera C, Maddox MK, et al: Triazolam in Alzheimer's disease: pilot study on sleep and memory effects. Pharmacol Biochem Behav 1995; 52:447-452
28. Savaskan E, Schnitzler C, Schroder C, et al: Treatment of behavioural, cognitive and circadian resteactivity cycle disturbances in Alzheimer's disease: haloperidol vs. quetiapine. Int J Neuropsychopharmacol 2006; 9:507-516
29. Kaynak H, Kaynak D, Gozukirmizi E, et al: The effects of trazodone on sleep in patients treated with stimulant antidepressants. Sleep Med 2004; 5:15-20
30. Roth AJ, McCall WV, Liguori A: Cognitive, psychomotor and polysomnographic effects of trazodone in primary insomniacs. J Sleep Res 2011; 20:552-558
31. Saletu-Zyhlarz GM, Abu-Bakr MH, Anderer P, et al: Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26:249-260
32. McCurry SM, Vitiello MV, Gibbons LE, et al: Factors associated with caregiver reports of sleep disturbances in persons with dementia. Am J Geriatr Psychiatry 2006; 14:112-120